Avid Bioservices Inc (CDMO)

[biopharm]

Could have the late Dr. Andrew Parsa also been on the fast track to quickly learning re: PS Targeting ?

This becomes a little shocking. Now, Dr. Wolchok has been working with platforms from the late (both young..) Dr. Philip Thorpe / Dr. Andrew Parsa.

Now we have a few immunotherapy researchers where many years were taken and cut short, en route to some historic paradigm shifts in medical treatment they would be part of changing Big Pharma legacy ways. Along with the late Dr. Phil Thorpe and Dr. Andrew Parsa... we can include Dr. Alan Escher:

Alan P. Escher, Ph.D.

Dr. Alan Escher received his BSc magna cum laude from the University of Connecticut and PhD from Cornell University. Dr. Escher was previously Associate Professor and Associate Director of the Center for Transplant Immunology Research at the Loma Linda University School of Medicine, where he and his colleagues started to develop pro-apoptotic DNA vaccination for the treatment of type 1 diabetes. His laboratory was among the first to report the beneficial effects of DNA vaccination for type 1 diabetes in 1999. Later, his team successfully translated the technology to prevention of skin allograft rejection as proof-of-concept for application to organ transplantation. In 2009, he began his transition from the academic setting. He co-founded SEKRIS Biomedical to translate apoptotic DNA immunotherapy for treatment of inflammatory disorders. As Executive Vice President of Technology Development, he continued to strengthen the patent portfolio. While his presence will be sorely missed, Dr. Escher’s legacy will continue through continued development of his work and realization of his vision to control unwanted inflammation with the ADI technology.

http://sekrisbiomedical.com/alan-escher/

Alice Li / Alan Escher ...

Publications

Alice Li and Alan Escher (2013). DNA Immunotherapies for Type 1 Diabetes – Type 1 Diabetes, Alan P. Escher and Alice Li (Eds.), ISBN: 978-953-51-1017-0, InTech. Chapter

Alice Li and Alan Escher (2011). Immunotherapy for Type 1 Diabetes – Preclinical and Clinical Trials, Type 1 Diabetes – Pathogenesis, Genetics and Immunotherapy, David Wagner (Ed.), ISBN: 978-953-307-362-0, InTech. Chapter

...
...
http://sekrisbiomedical.com/publications/

http://www.ctl.cornell.edu/about/staff/staff-members.php?sid=6

...
...The long-term goal is to ameliorate other inflammatory disorders including organ rejection. (I am 100% positive that PS Targeting would assist organ transplants)

sekrisbiomedical.com/company/

-------------------------------------

Shahrokh Shabahang

President at SEKRIS Biomedical, Inc.
Redlands, California
Biotechnology

Current
SEKRIS Biomedical, Inc., Loma Linda University

Previous
Victor Valley Endodontics, Genelux Corporation, University of the Pacific

Education
Loma Linda University

Experience
Co-founder and President/CEO
SEKRIS Biomedical, Inc.
July 2009 – Present (6 years 6 months)

Associate Professor
Loma Linda University
July 1997 – Present (18 years 6 months)

Endodontist/Partner
Victor Valley Endodontics
September 2005 – May 2010 (4 years 9 months)Victorville, CA

Private practice in endodontics
Director of Clinical Operations and Board Secretary
Genelux Corporation
August 2004 – November 2007 (3 years 4 months)Redlands, California

Assistant Professor
University of the Pacific
April 1992 – June 1995 (3 years 3 months)San Francisco, CA

Dentist/Partner
Sunnyvale Dental Care, Inc.
October 1987 – May 1995 (7 years 8 months)Sunnyvale, CA

Private practice in dentistry

Companies

Loma Linda University

Novo Nordisk

Sanford Health

Dakota Venture Group
Venture Capital & Private Equity

New Enterprise Associates (NEA)
Venture Capital & Private Equity

..
..
https://www.linkedin.com/in/shahrokh-shabahang-b02b4451

How may it fit in with Peregrine? well I've posted about many of the above, separate items... but James Carlson has ties to Sekris and Dakota Venture Group ties to NDSU and New Enterprise Associates ties to BMS...... of course we had the CSM ties to NDSU..etc..etc. More to come... but I am 100% that some know exactly how far some had gone to target Peregrine Pharmaceuticals.

James D. Carlson -68

Fargo, ND
West Fargo, ND
Stanley, ND
Redlands, CA
Charleston, SC

Pracs Institute , Ltd.
James Doran Company
Dakota REIT Management LLC
Cetero Research Company
Sekris Biomedical Inc
Research Corridor

Studied at:
University of Iowa

Relatives:
Sara Carlson
Chad Carlson
Christopher Carlson
Kathy Carlson
Joshua Carlson
Sonya Carlson

http://www.intelius.com/Find-Phone-Address/Fargo-ND/James-Carlson.html